Skip to main content

Table 1 Clinical characteristics of patients with triple negative breast cancer

From: Direct comparison of magnetic resonance imaging and pathological shrinkage patterns of triple-negative breast cancer after neoadjuvant chemotherapy

Factor

Median (range)

n

%

Total

 

34

 

Age (years)

53 (31–77)

  

Menopausal status

Premenopausal

11

32.4

Postmenopausal

20

58.8

Unknown

3

8.8

Histology

Invasive carcinoma, no special type

31

91.2

Invasive lobular carcinoma

1

2.9

Apocrine carcinoma

2

5.9

Initial clinical stage

I

10

29.4

IIA

10

29.4

IIB

9

26.5

IIIA

2

5.9

IIIB

1

2.9

IIIC

2

5.9

Ki-67

Low (≤ 20%)

2

5.9

High (> 20%)

29

85.3

Unknown

3

8.8

Lymph node metastasis

Present

15

44.1

Absent

19

55.9

Neoadjuvant chemotherapy regimen

Taxane

1

2.9

Taxane + anthracycline

33

97.1

Type of surgery

Radical mastectomy

11

32.4

Partial mastectomy

23

67.6